22 Percent: What the New Kidney Disease Number for Black Adults Actually Means
Year: 2026
Type: article
Abstract: Deep-research Numbers article on chronic kidney disease, explaining one disparity statistic with its definition, denominator, and limits. In CDC's Chronic Kidney Disease in the United States, updated March 2026 (NHANES August 2021-August 2023, CKD stages 1-4, CKD-EPI equation without race, single UACR/creatinine measure), CKD prevalence was 22% among non-Hispanic Black adults aged 18 and older versus 13% among non-Hispanic White adults and 12% among Hispanic adults; overall 14% (37 million). The article compares the previous 2023 report (about 20% vs about 12%, NHANES 2017-March 2020, 35.5 million), explains the race-free equation and methods change, reports awareness (87% of adults 20+ with CKD did not know), the diabetes (38%) and hypertension (21%) denominators, and the kidney-failure end from USRDS 2025 (131,564 started treatment in 2023; 831,192 living with ESKD; Black incidence 4x White). Supplement trials (berberine biomarkers, n=69; omega-3 in hemodialysis) are used only as a scale check. No supplement claim, recommendation, or product is made; kidney high-care box included. Evidence grade: STRONG. Educational article from the Buddha Ayurvedic School of Medicine: https://buddha.hospital
Author: Shu, Ajarn Shaman
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236147375
